发明公开
- 专利标题： HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF
- 专利标题（中）： MEK和杂环抑制剂的用途，以便方法
-
申请号： EP06836069.2申请日： 2006-05-17
-
公开(公告)号： EP1922307A2公开(公告)日： 2008-05-21
- 发明人: MARLOW, Allison, L. , WALLACE, Eli , SEO, Jeongbeob , LYSSIKATOS, Joseph, P. , YANG, Hong, Woon , BLAKE, Jim , STOREY, Richard, Anthony , BOOTH, Rebecca, Jane , PITTAM, John, David , LEONARD, John , FIELDING, Mark, Richard
- 申请人： Array Biopharma, Inc. , AstraZeneca AB
- 申请人地址： 3200 Walnut Street Boulder, CO 80301 US
- 专利权人： Array Biopharma, Inc.,AstraZeneca AB
- 当前专利权人： Array Biopharma, Inc.,AstraZeneca AB
- 当前专利权人地址： 3200 Walnut Street Boulder, CO 80301 US
- 代理机构： Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
- 优先权： US682335P 20050518
- 国际公布： WO2007044084 20070419
- 主分类号： C07D213/84
- IPC分类号： C07D213/84 ; C07D213/63 ; A61K31/44
摘要：
Disclosed are MEK inhibitors useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
公开/授权文献
- EP1922307B1 HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF 公开/授权日：2011-12-28
信息查询
IPC分类:
